Biotech et investissements : Décryptage du marché 

Biotechnology now occupies a strategic position in investment portfolios, at the crossroads of scientific innovation, global health issues and international macroeconomic dynamics.

In this constantly evolving context, BioPark Charleroi, in collaboration with Belfius Namur-Hainaut Sud, invites you to a conference dedicated to analysing key trends in the biotech market and presenting the Candriam Equities L Biotechnology fund.

This session will offer an insight into the current dynamics of the sector, investment cycles and medium-term prospects, while providing a privileged space for exchange between professionals, investors and players in the ecosystem.

Why participate?

• To understand trends in the biotechnology market.
• To identify levers for value creation in an uncertain context.
• Benefit from the combined vision of experts in fund management and investment strategy
• Engage in high-quality discussions in a networking-friendly environment

Speakers

• Pierre Vaurice – Fund Manager | Global Equities, Candriam
• Eric Flecijn – Senior Business Development Manager Distribution Partners, Candriam Investors Group
• Nicolas Deltour – Chief Investment Strategist, Belfius Private

Agenda
5.30 p.m. – Welcome

6 p.m. – Conference

• Introduction by Dominique Demonté (BioPark Charleroi) and Mathieu Gilot (Belfius Namur-Hainaut Sud)
• Analysis of the biotech market
• Investment trends and outlook
• Focus on the Candriam Equities L Biotechnology fund

7.30pm – Walking dinner & networking

Participation is free, but registration is required to ensure smooth organisation and high-quality discussions.